therefore , future efforts must be directed at defining the natural history and infectivity of individuals showing evidence of htlv iii or lav infection and toward specific antiviral therapy for those with infection and a vaccine for those at high risk for htlv iii infection and , consequently , aids .
C0019693
htlv iii infection
C0001175
aids